Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

ContextLogic Already Imposed the Pain That Hurts… Now for the Pain That Alters

By Josh Enomoto, InvestorPlace Contributor

Although we live in a period where anything can happen, you don’t want to let that be the core reason to hold WISH stock.

Novavax Appears to be Running Out of Options

By Josh Enomoto, InvestorPlace Contributor

With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an abandon-ship investment at this point.

7 Small-Cap Stocks to Buy for Big Results in 2022

By Josh Enomoto, InvestorPlace Contributor

Although several discounts are in play due to recent market volatility, these small-cap stocks may deliver a much bigger bang for your buck.

7 Housing Stocks to Watch as Investors Question the Bull Thesis

By Josh Enomoto, InvestorPlace Contributor

Although real estate experts suggest higher prices are here to stay for 2022, housing stocks suggest something far different.

Is Social Media Giving Off Hints of ContextLogic’s Fissures?

By Josh Enomoto, InvestorPlace Contributor

Although WISH stock once carried speculator hopes, the vituperative nature of its social media posts may be a sign -- a bad one.

Before You Buy Tezos, Determine Whether It Is on the Critical Path

By Josh Enomoto, InvestorPlace Contributor

While Tezos generates headlines for its incredible utility and technical prowess, investors must ask whether that all matters.

7 Stocks to Buy for a Year Full of Volatility and Rate Hikes

By Josh Enomoto, InvestorPlace Contributor

With so much uncertainty baked into the coming rate hikes throughout 2022, now is the time to consider certain stocks to buy.

Zomedica Stock Should Have Popped on This Latest Acquisition, so Beware

By Josh Enomoto, InvestorPlace Contributor

Although ZOM stock has some exciting news to undergird its price tag, that hardly anything has changed is worrying.

After Cardano Halved, ADA is Acting Quite the Tease and It’s Disturbing

By Josh Enomoto, InvestorPlace Contributor

Though Cardano enjoys multiple positive catalysts, ADA remains as volatile as ever, suggesting a broader lack of belief.

7 Overrated Stocks to Avoid Like the Plague

By Josh Enomoto, InvestorPlace Contributor

While 2021 has been rocket fuel for the equities sector, there are some stocks to avoid as we enter a different environment in 2022.

Load More